MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 10 - per page
Order by
Decapinol™ rinse contains a cationic surfactant Delmopinol Hydrochloride 2mg/ml; Decapinol rinse has a unique mode of action, which prevents the attachment as well as the adherence of plaque bacteria to the teeth, gingiva and to itself. More
Decapinol toothpaste containing Sodium Fluoride (NaF) 0.11% and Delmopinol 0.2% is a new addition to the Decapinol family and is indicated for the treatment of gingivitis and periodontitis. More
Decapinol Gel, offers a novel and convenient way of treating periodontal disease. It contains 3 key ingredients - Delmopinol Hydrochloride (5mg/ml), Polyvinylpyrrolidone (PVP) and Hyaluronic Acid. More
Suite of proprietary collagen-binding peptides derived from bone sialoprotein (BSP) that are effective in promoting bone repair and regeneration. More
Decapinol Spray is the most recent line extension of Decapinol mouth rinse, Decapinol toothpaste and Decapinol Gel, and provides both the clinician and patient with an alternative in treating gingivitis and periodontitis. More
This TACE inhibitory protein could be used as a new therapeutic agent against chronic inflammatory diseases that are mediated by TNF-alpha. More
Decapinol Gum Applicator offers a novel and convenient way of treating periodontal disease. The unique delivery system was developed specifically for dental professionals; its unique ergonomic design makes it easy to apply. More
A platform technology that enables the coating of biological and non-biological surfaces with a matrix capable of sustained release of various active agents currently applied systemically or topically, thereby increasing effectiveness and reducing... More
Name of the inventors: Helen Lu & Gunnar Hasselgren The Challenge/ Problem/ Unmet Need The health of a human tooth depends on the integrity of the dental hard tissues and the support of living soft tissues. The enamel is the outer hard layer of the tooth. More
Name of the inventor: Steven P. Engebretson DDS, PhD Methods for facilitating metabolic control and for decreasing the level of circulating TNF in a subject are described. The use of anti-inflammatory agents in these methods is also discussed. The method. More
Displaying 1..10 of 10 - per page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us